Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
agile, America, animal, antitumor, appointed, array, bearing, bind, binding, bioavailability, biodistribution, bound, capecitabine, Chase, Chen, cisplatin, College, constant, cooperative, deferral, degree, dehydrogenase, departure, derived, died, differentiated, differentiation, difficult, diffusion, dozen, durable, Dx, Emory, emtansine, energy, entry, enzyme, equivalent, explanation, facilitate, feedback, fill, flat, Fox, free, heat, heavily, Herceptin, hope, illustrate, Importantly, IND, inefficient, Interestingly, irinotecan, lactate, Langone, leverage, London, melanoma, mesothelioma, metabolite, mice, month, MTD, nominal, nominate, North, notified, pancreatic, partial, passive, PDX, pending, people, pertuzumab, Philadelphia, play, pleural, pretreated, proportion, proposed, quantifiable, radiation, rectal, reliant, rely, respond, Schor, SCLC, shock, solubility, stimulated, submission, systemic, team, toxicity, toxicology, transporter, triplet, undergoing, vacancy, variability, viable, Vice, weekly, World, xenograft, York
Removed:
abiraterone, affiliate, allergy, alopecia, asthma, autoimmune, bendamustine, bortezomib, broker, carboplatin, carcinoma, channel, chronic, commercializing, consistently, COPD, correlate, creating, creation, crizotinib, cytokine, dealer, degranulation, diminished, direct, directing, discovered, discovering, distinguish, door, doxorubicin, driven, eliminating, engine, enhance, epigenetic, escalating, expressed, extend, focusing, found, function, home, immune, improving, inactive, inflammatory, inhibiting, integrated, intent, internally, International, involving, ion, IV, killing, kinase, lenalidomide, library, liver, mainstay, mast, medium, mitochondria, moderate, modulating, mutation, neurotoxicity, NYC, obstructive, ocular, opening, overexpression, ownership, oxygen, panobinostat, participating, partner, pharmacology, pipeline, placement, pomalidomide, potency, pulmonary, purely, RA, radiolabeled, registered, rejection, repaid, retain, rheumatoid, shared, sized, sorafenib, stemmed, strong, sunitinib, temozolomide, topotecan, translocation, transplant, treating, underwriter, vitro, vorinostat, weak
Filing tables
Filing exhibits
MDGL similar filings
Filing view
External links